Mousa, Nour
Aiesh, Banan M.
Jomaa, Ruba
Zouneh, Yousef
Namrouti, Ashraqat
Abutaha, Adham
Al-Jabi, Samah W.
Sabateen, Ali
Zyoud, Sa’ed H.
Article History
Received: 20 January 2025
Accepted: 16 July 2025
First Online: 22 July 2025
Declarations
:
: The authors declare no competing interests.
: The study protocol, which involved the use of patient clinical data, was approved by the Institutional Review Boards (IRBs) at An-Najah National University (Pharm.Sep.2022/25). Permission to access patient records was also granted by An-Najah National University Hospital. Due to the retrospective nature of the study and the use of anonymized data, the IRB of An-Najah National University waived the need for informed consent. All research procedures adhered to the principles outlined in the Declaration of Helsinki and complied with relevant guidelines and regulations. Data confidentiality was rigorously maintained, with all information used solely for clinical research purposes. Identifiable data were replaced with numerical codes to ensure patient privacy.
: Not applicable.